Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


p2,0_3E5E_luciferase Citations (1)

Originally described in: The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.
Trunschke M, Conrad D, Enterlein S, Olejnik J, Brauburger K, Muhlberger E Virology. 2013 Jul 5;441(2):135-45. doi: 10.1016/j.virol.2013.03.013. Epub 2013 Apr 11.
PubMed Journal

Articles Citing p2,0_3E5E_luciferase

Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System. Levine CB, Mire CE, Geisbert TW. J Virol. 2021 Sep 27;95(20):e0064321. doi: 10.1128/JVI.00643-21. Epub 2021 Aug 11. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.